Amarin Corp Plc (AMRN)

[Whalatane]

N7. Generic’s is a low profit business … which is why NVS is thinking of dumping theirs
Generic CO’s make what $ they make by drastically cutting overhead costs and selling multiple generics ….. ie spreading the costs

Why would Kaiser ( known for driving costs down by using generic ) be using brand V instead of generic V ?

Because
1) they know their CAD patients like me are only using it for the R-It indication … so don’t want to be dragged into a HealthNet like court case
2) AMRN gave them a lower price then the generics
3) combination of 1) and 2)

Name any Co making significant profit selling generics

Kiwi